Skip to Main Content

Author Details

Yorihisa Imanishi
International University of Health and Welfare, Narita Hospital
1996
70
21
PMIDPaper TitleJournal TitlePublished Year
37464232Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma.Virchows Arch2023
37006915Pain in the neck: Bench press injury.J Am Coll Emerg Physicians Open2023
34245171Pretherapeutic Predictive Factors for Histological High-Grade Parotid Gland Carcinoma.Laryngoscope2022
36333410Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.NPJ Precis Oncol2022
36090801Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma.Ther Adv Med Oncol2022
36387194Midline involvement and perineural invasion predict contralateral neck metastasis that affects overall and disease-free survival in locally advanced oral tongue squamous cell carcinoma.Front Oncol2022
35186711The Role of the EZH2 and H3K27me3 Expression as a Predictor of Clinical Outcomes in Salivary Duct Carcinoma Patients: A Large-Series Study With Emphasis on the Relevance to the Combined Androgen Blockade and HER2-Targeted Therapy.Front Oncol2022
34591159Clinical impact of perioperative atrial fibrillation on long-term recurrence of malignancy.Heart Vessels2022
32673437Prognostic Value of the Lymphocyte-to-Monocyte Ratio in Patients with Parotid Gland Carcinoma.Laryngoscope2021
34084214Cyclooxygenase-2 expression is associated with chemoresistance through cancer stemness property in hypopharyngeal carcinoma.Oncol Lett2021
32269737Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer.Am J Transl Res2020
31764219Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model.Am J Surg Pathol2020
32103349The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma.Virchows Arch2020
31063466Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy.PLoS One2019
31679617Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence.Can J Cardiol2019
31177149Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients.Anticancer Res2019
31570459Cyclo-oxygenase-2 Expression Is Associated With Lymph Node Metastasis in Oropharyngeal Squamous Cell Carcinoma Under the New TNM Classification.Anticancer Res2019
29160008Clinical diagnosis and treatment outcomes for parapharyngeal space schwannomas: A single-institution review of 21 cases.Head Neck2018
29940875The study protocol for PREDICT AF RECURRENCE: a PRospEctive cohort stuDy of surveIllanCe for perioperaTive Atrial Fibrillation RECURRENCE in major non-cardiac surgery for malignancy.BMC Cardiovasc Disord2018
29993139The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.Histopathology2018
30416855VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner.Am J Cancer Res2018
29721176Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma.Oncotarget2018
27894101Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.Oncotarget2017
29416736Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas.Oncotarget2017
28938615Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.Oncotarget2017
28651556Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer.BMC Cancer2017
26790669Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.Ann Surg Oncol2016
27459817[Usefulness and Limitation of Thyroglobulin Measurement in Fine Needle Aspirates (FNA-Tg) for Diagnosis of Neck Lymph Node Metastasis from Thyroid Carcinoma].Nihon Jibiinkoka Gakkai Kaiho2016
25789955PiCO2 monitoring of transferred jejunum perfusion using an air tonometry technique after hypopharyngeal cancer surgery.Medicine (Baltimore)2015
26483189Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.BMC Cancer2015
26482848Identification of protein arginine N-methyltransferase 5 (PRMT5) as a novel interacting protein with the tumor suppressor protein RASSF1A.Biochem Biophys Res Commun2015
24956743[Clinical outcome and clinicopathological prognostic factors in adenoid cystic carcinoma of the head and neck].Nihon Jibiinkoka Gakkai Kaiho2014
25033838Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan.Oncology2014
24887090Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma.J Exp Clin Cancer Res2014
24191589[Survival analysis and immunohistochemical study of HER-2 and AR (androgen receptor) expression in salivary duct carcinoma].Nihon Jibiinkoka Gakkai Kaiho2013
21913013Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.Ann Surg Oncol2012
23016269[Statistical analysis of 32 patients with nasopharyngeal carcinoma].Nihon Jibiinkoka Gakkai Kaiho2012
23083481Transoral anterior approach using median mandibular splitting in upper spinal tumor extirpation.Oral Surg Oral Med Oral Pathol Oral Radiol2012
20652641Tumor depth as a predictor of lymph node metastasis of supraglottic and hypopharyngeal cancers.Ann Surg Oncol2011
22352010[Thyroglobulin concentration measurement in fine-needle aspiration fluid from cystic cervical lymph node metastases of papillary thyroid carcinoma].Nihon Jibiinkoka Gakkai Kaiho2011
21680733Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.J Biol Chem2011
20421861Complicated surgical resection of malignant tumors in the upper cervical spine after failed ion-beam radiation therapy.Spine (Phila Pa 1976)2010
18635326Experimental evaluation of relapse-risks in operated zygoma fractures.Auris Nasus Larynx2009
18520898An anatomical study of the three-dimensional structure of the nasal septum in patients with alveolar clefts and alveolar-palatal clefts.Plast Reconstr Surg2008
17483337Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway.Cancer Res2007
17369861Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.Oncogene2007
16424009Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway.Cancer Res2006
15743799Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma.Am J Pathol2005
15006520Extended sigmoid-shaped free jejunal patch for reconstruction of the oral base and pharynx after total glossectomy with laryngectomy.Br J Plast Surg2004
15364371Two cases of pulmonary embolism after head and neck surgery.Auris Nasus Larynx2004
  • 1 - 50 of 70

Recommended Authors

Krupal B Patel
Moffitt Cancer Center
Career Start Year 2013
Number of shared co-authors 0
Stefan Hartmann
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 0
Chao Liu
Xiangya Hospital, Central South University
Career Start Year 2013
Number of shared co-authors 3
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 3
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 0
Daniel R Clayburgh
Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 0
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Jun Furusawa
Aichi Cancer Center Hospital
Career Start Year 2003
Number of shared co-authors 0
Kathrin Scheckenbach
Heinrich-Heine University
Career Start Year 2002
Number of shared co-authors 0
Tito Poli
University Hospital of Parma
Career Start Year 2001
Number of shared co-authors 0
Anthony C Nichols
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 0
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 3
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Mark W Lingen
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Jonathan C Irish
Princess Margaret Cancer Centre
Career Start Year 1992
Number of shared co-authors 0
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Charles R Leemans
Location Vrije Universiteit Amsterdam
Career Start Year 1990
Number of shared co-authors 0
Kenji Kawano
Oita University
Career Start Year 1990
Number of shared co-authors 0
Jennifer R Grandis
University of California san francisco
Career Start Year 1988
Number of shared co-authors 3
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Jay O Boyle
Memorial Sloan Kettering Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Michael P Hier
Jewish General Hospital, McGill University
Career Start Year 1987
Number of shared co-authors 0
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 0
Wayne M Koch
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 0
Shigetaka Yanagisawa
Gunma University Graduate School of Medicine
Career Start Year 1981
Number of shared co-authors 0

Collaborators

Akihiro Sakai
Tokai University
Co-authored papers 9
Mizuo Ando
University of Tokyo
Co-authored papers 7
Bo Hu
Northwestern University Feinberg School of Medicine
Co-authored papers 5
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Co-authored papers 5
Michael J Jarzynka
Division of Pharmaceutical Sciences, Duquesne University School of Pharmacy
Co-authored papers 4
Ping Guo
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Co-authored papers 4
Takanori Hirose
Hyogo Cancer Center
Co-authored papers 2
Ifat Bar-Joseph
The Center for Cancer Research-Sheba Medical Center
Co-authored papers 2
Ryo Nishikawa
Saitama Medical University International Medical Center
Co-authored papers 2
Hiroyuki Mano
Co-authored papers 1
Yuki Saito
Niigata Prefectural Tokamachi Hospital.
Co-authored papers 1
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers 1
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers 1
Kaoru Saijo
Helen Wills Neuroscience Institute, University of California berkeley
Co-authored papers 1
Release 1.2